Glucocorticoid "programming" and PTSD risk

Annals of the New York Academy of Sciences

Volumn 1071, Issue , 2006, Pages 351-378

  Seckl, Jonathan R ^a,c   Meaney, Michael J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase type 2; Amygdala; Fetal programming; Glucocorticoid receptor; Glucocorticoids; Hippocampus; Hypothalamic pituitary adrenal axis; Stress

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BETAMETHASONE; CARBENOXOLONE; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLUCOSE; INSULIN; PREDNISOLONE; PREDNISONE; STEROID;

AMYGDALOID NUCLEUS; ANXIETY; ASTHMA; ATTENTION DISTURBANCE; BEHAVIOR; BEHAVIOR DISORDER; BEHAVIORAL SCIENCE; BIRTH WEIGHT; BLOOD PRESSURE; BRAIN DYSFUNCTION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM FUNCTION; CONFERENCE PAPER; CORRELATION ANALYSIS; DISTRACTIBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; FERTILIZATION; FETOPLACENTAL UNIT; GENE MUTATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEAD CIRCUMFERENCE; HEART; HIPPOCAMPUS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN METABOLISM; INTELLIGENCE QUOTIENT; LIFESPAN; LOW BIRTH WEIGHT; MENTAL DISEASE; METABOLIC DISORDER; NEUROENDOCRINE DISEASE; NEUROPSYCHIATRY; NONHUMAN; PANCREAS; POSTTRAUMATIC STRESS DISORDER; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PROGENY; RISK ASSESSMENT; SIDE EFFECT; STRESS; WEIGHT REDUCTION;

ANIMALIA;

EID: 33746468080     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1364.027     Document Type: Conference Paper

References (207)

1. BARKER, D.J.P., P.D. GLUCKMAN, K.M. GODFREY, et al. 1993. Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938-941.
2. EDWARDS, C.R.W., R. BENEDIKTSSON, R. LINDSAY & J.R. SECKL. 1993. Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension? Lancet 341: 355-357.
3. SECKL, J.R. 1998. Physiologic programming of the fetus. Clin. Perinatol. 25: 939-964.
4. CSABA, G. 1986. Receptor ontogeny and hormonal imprinting. Experientia 42: 750-758.
5. ARAI, Y. & R.A. GORSKI. 1968. Critical exposure time for androgenization of the developing hypothalamus in the female rat. Endocrinology 82: 1010-1014.
6. GUSTAFSSON, J.-A., A. MODE, G. NORSTEDT & P. SKETT. 1983. Sex steroid-induced changes in hepatic enzymes. Ann. Rev. Physiol. 45: 51-60.
7. SIMERLY, R.B. 2002. Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Annu. Rev. Neurosci. 25: 507-536.
8. DAVIS, E.C., P. POPPER & R.A. GORSKI. 1996. The role of apoptosis in sexual differentiation of the rat sexually dimorphic nucleus of the preoptic area. Brain Res. 734: 10-18.
9. BARKER, D.J.P. 1991. Fetal and Infant Origins of Adult Disease. BMJ 343: 1111.
10. BARKER, D.J.P., C.N. HALES, C.H.D. FALL, et al. 1993. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67.
11. LITHELL, H.O., P.M. MCKEIGUE, L. BERGLUND, et al. 1996. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br. Med. J. 312: 406-410.
12. CURHAN, G.C., G.M. CHERTOW, W.C. WILLETT, et al. 1996. Birth-weight and adult hypertension and obesity in women. Circulation 94: 1310-1315.
13. CURHAN, G.C., W.C. WILLETT, E.B. RIMM, et al. 1996. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94: 3246-3250.
14. FALL, C.H.D., C. OSMOND, D.J.P. BARKER, et al. 1995. Fetal and infant growth and cardiovascular risk factors in women. Br. Med. J. 310: 428-432.
15. FORSEN, T., J.G. ERIKSSON, J. TUOMILEHTO, et al. 1997. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow-up study. Br. Med. J. 315: 837-840.
16. LEON, D.A., I. KOUPILOVA, H.O. LITHELL, et al. 1996. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50-year-old Swedish men. Br. Med. J. 312: 401-406.
17. MOORE, V.M., A.G. MILLER, T.J.C. BOULTON, et al. 1996. Placental weight, birth measurements, and blood pressure at age 8 years. Arch. Dis. Child. 74: 538-541.
18. RICH-EDWARDS, J.W., M.J. STAMPFER, J.E. MANSON, et al. 1997. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br. Med. J. 315: 396-400.
19. YAJNIK, C.S., C.H.D. FALL, U. VAIDYA, et al. 1995. Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet. Med. 12: 330-336.
20. BARKER, D.J.P., A.R. BULL, C. OSMOND & S.J. SIMMONDS. 1990. Fetal and placental size and risk of hypertension in adult life. Br. Med. J. 301: 259-263.
21. IRVING, R.J., N.R. BELTON, R.A. ELTON & B.R. WALKER. 2000. Adult cardiovascular risk factors in premature babies. Lancet 355: 2135-2136.
22. OSMOND, C., D.J.P. BARKER, P.D. WINTER, et al. 1993. Early growth and death from cardiovascular disease in women. Br. Med. J. 307: 1524-1527.
23. LEVINE, R.S., C.H. HENNEKENS & M.J. JESSE. 1994. Blood pressure in prospective population based cohort of newborn and infant twins. Br. Med. J. 308: 298-302.
24. BAVDEKAR, A., C.S. YAJNIK, C.H. FALL, et al. 1999. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48: 2422-2429.
25. LAW, C.M., A.W. SHIELL, C.A. NEWSOME, et al. 2002. Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation 105: 1088-1092.
26. BAIRD, J., C. OSMOND, A. MACGREGOR, et al. 2001. Testing the fetal origins hypothesis in twins: the Birmingham twin study. Diabetologia 44: 33-39.
27. SECKL, J.R. & B.R. WALKER. 2001. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 142: 1371-1376.
28. GALE, C.R., C.N. MARTYN, S. KELLINGRAY, et al. 2001. Intrauterine programming of adult body composition. J. Clin. Endocrinol. Metab. 86: 267-272.
29. TANGALAKIS, K., E.R. LUMBERS, K.M. MORITZ, et al. 1992. Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp. Physiol. 77: 709-717.
30. BERRY, L.M., D.H. POLK, M. IKEGAMI, et al. 1997. Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 41: R1972-R1979.
31. KARI, M.A., M. HALLMAN, M. ERONEN, et al. 1994. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 93: 730-736.
32. REINISCH, J.M., N.G. SIMON, W.G. KARWO & R. GANDELMAN. 1978. Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science 202: 436-438.
33. NYIRENDA, M.J., R.S. LINDSAY, C.J. KENYON, et al. 1998. Glucocorticoid exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101: 2174-2181.
34. IKEGAMI, M., A.H. JOBE, J. NEWNHAM, et al. 1997. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am. J. Respir. Crit. Care Med. 156: 178-184.
35. FRENCH, N.P., R. HAGAN, S.F. EVANS, et al. 1999. Repeated antenatal corticosteroids: size at birth and subsequent development. Am. J. Obstet. Gynecol. 180: 114-121.
36. NEWNHAM, J.P., S.F. EVANS, M. GODFREY, et al. 1999. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J. Matern. Fetal Med. 8: 81-87.
37. NEWNHAM, J.P. & T.J. MOSS. 2001. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin. Neonatol. 6: 285-292.
38. BLOOM, S.L., J.S. SHEFFIELD, D.D. MCINTIRE & K.J. LEVENO. 2001. Antenatal dexamethasone and decreased birth weight. Obstet. Gynecol. 97: 485-490.
39. FOREST, M.G., M. DAVID & Y. MOREL. 1993. Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 45: 75-82.
40. MERCADO, A.B., R.C. WILSON, K.C. CHENG, et al. 1995. Prenatal treatment and diagnosis of congential adrenal hyperlasia owing to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80: 2014-2020.
41. MURPHY, V.E., T. ZAKAR, R. SMITH, et al. 2002. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J. Clin. Endocrinol. Metab. 87: 1660-1668.
42. GOLAND, R.S., S. JOZAK, W.B. WARREN, et al. 1993. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endo. Metab. 77: 1174-1179.
43. GOLAND, R.S., P.J. TROPPER, W.B. WARREN, et al. 1995. Concentrations of corticotropin-releasing hormone in the umbilical-cord blood of pregnancies complicated by preeclampsia. Reprod. Fertil. Dev. 7: 1227-1230.
44. GUNBERG, D.L. 1957. Some effects of exogenous hydrocortisone on pregnancy in the rat. Anat. Res. 129: 133-153.
45. WARD, R.M. 1994. Pharmacologic enhancement of fetal lung maturation. Clin. Perinatol. 21: 523-542.
46. COLE, T.J. 1995. Cloning of the mouse 11beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136: 4693-4696.
47. SPEIRS, H., J. SECKL & R. BROWN. 2004. Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J. Endocrinol. 181: 105-116.
48. BROWN, R.W., R. DIAZ, A.C. ROBSON, et al. 1996. The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137: 794-797.
49. SUN, K., K. YANG & J.R.G. CHALLIS. 1997. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J. Clin. Endocrinol. Metab. 82: 300-305.
50. BEITENS, I.Z., F. BAYARD, I.G. ANCES, et al. 1973. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr. Res. 7: 509-519.
51. KLEMCKE, H.G. 1995. Placental metabolism of cortisol at mid-and late gestation in swine. Biol. Reprod. 53: 1293-1301.
52. WHITE, P.C., T. MUNE & A.K. AGARWAL. 1997. 11beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18: 135-156.
53. LOPEZ-BERNAL, A., A.P.F. FLINT, A.B.M. ANDERSON & A.C. TURNBULL. 1980. 11β-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J. Steroid Biochem. 13: 1081-1087.
54. LOPEZ BERNAL, A. & I.L. CRAFT. 1981. Corticosteroid metabolism in vitro by human placenta, foetal membranes and decidua in early and late gestation. Placenta 2: 279-285.
55. BENEDIKTSSON, R., A.A. CALDER, C.R.W. EDWARDS & J.R. SECKL. 1997. Placental 11β-hydroxy steroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin. Endocrinol. 46: 161-166.
56. BROWN, R.W., Y. KOTOLEVTSEV, C. LECKIE, et al. 1996. Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. Biochem. J. 313: 1007-1017.
57. WADDELL, B.J. & H.C. ATKINSON. 1994. Production rate, metabolic clearance rate and uterine extraction of corticosterone during rat pregnancy. J. Endocrinol. 143: 183-190.
58. WADDELL, B., R. BENEDIKTSSON, R. BROWN & J.R. SECKL. 1998. Tissue-specific mRNA expression of 11B-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggest exquisite local control of glucocorticoid action. Endocrinology 139: 1517-1523.
59. VENIHAKI, M.A., P. CARRIGAN, P. DIKKES & J. MAJZOUB. 2000. Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proc. Natl. Acad. Sci. USA 97: 7336-7341.
60. ALBISTON, A.L., V.R. OBEYESEKERE, R.E. SMITH & Z.S. KROZOWSKI. 1994. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105: R11-R17.
61. HOLMES, M., M. SANGRA, K. FRENCH, et al. 2005. 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 137: 865-873.
62. BENEDIKTSSON, R., R. LINDSAY, J. NOBLE, et al. 1993. Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet 341: 339-341.
63. STEWART, P.M., F.M. ROGERSON & J.I. MASON. 1995. Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab. 80: 885-890.
64. MCTERNAN, C.L., N. DRAPER, H. NICHOLSON, et al. 2001. Reduced placental 11 beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab. 86: 4979-4983.
65. SHAMS, M., M.D. KILBY, D.A. SOMERSET, et al. 1998. 11beta hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth retardation. Hum. Reprod. 13: 799-804.
66. ROGERSON, F.M., K. KAYES & P.C. WHITE. 1996. No correlation in human placenta between activity or mRNA for the K (type 2) isozyme of 11β-hydroxysteroid dehydrogenase and fetal or placental weight. Tenth International Congress of Endocrinology Abstracts P1 231: 193.
67. ROGERSON, F.M., K.M. KAYES & P.C. WHITE. 1997. Variation in placental type 2 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol. Cell. Endocrinol. 128: 103-109.
68. BENEDIKTSSON, R., J. BRENNAND, L. TIBI, et al. 1995. Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin. Endocrinol. 42: 551-555.
69. DAVE-SHARMA, S., R.C. WILSON, M.D. HARBISON, et al. 1998. Extensive personal experience: examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 83: 2244-2254.
70. KOTELEVTSEV, Y., R.W. BROWN, S. FLEMING, et al. 1999. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 103: 683-689.
71. HOLMES, M.C., L.A. WELBERG & J.R. SECKL. 2002. Early life programming of the brain by glucocorticoids. 5th International Congress of Neuroendocrinology, Bristol, UK. S57.
72. LANGLEY-EVANS, S.C., G. PHILIPS, R. BENEDIKTSSON, et al. 1996. Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 17: 169-172.
73. BERTRAM, C., A.R. TROWERN, N. COPIN, et al. 2001. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 142: 2841-2853.
74. LESAGE, J., B. BLONDEAU, M. GRINO, et al. 2001. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 142: 1692-1702.
75. LANGLEY-EVANS, S.C. 1997. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertens. 15: 537-544.
76. KOENEN, S.V., C.A. MECENAS, G.S. SMITH, et al. 2002. Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am.J. Obstet. Gynecol. 186: 812-817.
77. DODIC, M., K. MORITZ, I. KOUKOULAS & E.M. WINTOUR. 2002. Programmed hypertension: kidney, brain or both? Trends Endocrinol. Metab. 13: 403-408.
78. DODIC, M., V. HANTZIS, J. DUNCAN, et al. 2002. Programming effects of short prenatal exposure to cortisol. FASEB J. 16: 1017-1026.
79. DODIC, M., A. PEERS, J. COGHLAN, et al. 1999. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin. Sci. 97: 103-109.
80. DODIC, M., C.N. MAY, E.M. WINTOUR & J.P. COGHLAN. 1998. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci. 94: 149-155.
81. JENSEN, E.C., B.W. GALLAHER, B.H. BREIER & J.E. HARDING. 2002. The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep. J. Endocrinol. 174: 27-36.
82. LEVITT, N., R.S. LINDSAY, M.C. HOLMES & J.R. SECKL. 1996. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64: 412-418.
83. SUGDEN, M.C., M.L. LANGDOWN, M.J. MUNNS & M.J. HOLNESS. 2001. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur. J. Endocrinol. 145: 529-539.
84. GATFORD, K.L., E.M. WINTOUR, M.J. DE BLASIO, et al. 2000. Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin. Sci. 98: 553-560.
85. LINDSAY, R.S., R.M. LINDSAY, C.R.W. EDWARDS & J.R. SECKL. 1996. Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27: 1200-1204.
86. LINDSAY, R.S., R.M. LINDSAY, B. WADDELL & J.R. SECKL. 1996. Programming of glucose tolerance in the rat: role of placenta 11β-hydroxysteroid dehydrogenase. Diabetologia 39: 1299-1305.
87. CHAYTOR, A., I. HUTTCHESON & T. GRIFFITH. 2000. Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium 7: 265-278.
88. HOLMES, M., J. YAU, Y. KOTELEVTSEV, et al. 2003. 11β-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Ann. N. Y. Acad. Sci. 1007: 357-366.
89. ROLAND, B.L., K.X.Z. LI & J.W. FUNDER. 1995. Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 136: 4697-4700.
90. ROBSON, A.C., C. LECKIE, J.R. SECKL & M.C. HOLMES. 1998. Expression of 11β-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Mol. Brain Res. 61: 1-10.
91. DIAZ, R., R.W. BROWN & J.R. SECKL. 1998. Ontogeny of mRNAs encoding glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenases in prenatal rat brain development reveal complex control of glucocorticoid action. J. Neurosci. 18: 2570-2580.
92. ORTIZ, L.A., A. QUAN, A. WEINBERG & M. BAUM. 2001. Effect of prenatal dexamethasone on rat renal development. Kidney Int. 59: 1663-1669.
93. WINTOUR, E.M., K.M. MORITZ, K. JOHNSON, et al. 2003. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J. Physiol. (Lond.) 549: 929-935.
94. MOLNAR, J., M.J.M. NIJLAND, D.C. HOWE & P.W. NATHANIELSZ. 2002. Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 283: R561-R567.
95. MOLNAR, J., D.C. HOWE, M.J.M. NIJLAND & P.W. NATHANIELSZ. 2003. Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J. Physiol. (Lond.) 547: 61-66.
96. DOCHERTY, C., J. KALMAR-NAGY, M. ENGELEN & P.J. NATHANIELZ. 2001. Effect of in vivo infusion of dexamethasone at 0.75 gestation on responses to endothelin-1 in isolated fetal ovine resistance arteries. Am. J. Physiol. 281: R261-R268.
97. DODIC, M., R. BAIRD, V. HANTZIS, et al. 2001. Organs/systems potentially involved in one model of programmed hypertension in sheep. Clin. Exp. Pharmacol. Physiol. 28: 952-956.
98. MORITZ, K.M., K. JOHNSON, R. DOUGLAS-DENTON, et al. 2002. Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology 143: 4455-4463.
99. BARKER, D.J.P., P.D. WINTER, C. OSMOND, et al. 1989. Weight in infancy and death from ischaemic heart disease. Lancet ii: 577-580.
100. BIAN, X.P., F.J. SEIDLER & T.A. SLOTKIN. 1993. Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology 47: 109-117.
101. BIAN, X.P., F.J. SEIDLER & T.A. SLOTKIN. 1992. Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J. Dev.Physiol. 17: 289-297.
102. LANGDOWN, M.L., N.D. SMITH, M.C. SUGDEN & M.J. HOLNESS. 2001. Excessive glucocorticoid exposure during late intrauterine development modulates the expression of cardiac uncoupling proteins in adult hypertensive male offspring. Pflugers Arch. 442: 248-255.
103. LANGDOWN, M.L., M.J. HOLNESS & M.C. SUGDEN. 2001. Early growth retardation induced by excessive exposure to glucocorticoids in utero selectively increases cardiac GLUT1 protein expression and Akt/protein kinase B activity in adulthood. J. Endocrinol. 169: 11-22.
104. LANGDOWN, M.L., M.J. HOLNESS & M.C. SUGDEN. 2003. Effects of prenatal glucocorticoid exposure on cardiac calreticulin and calsequestrin protein expression during early development and in adulthood. Biochem. J. 371: 61-69.
105. LESAGE, J., F. DEL-FAVERO, M. LEONHARDT, et al. 2004. Prenatal stress induces intrauterine growth restriction and programmes glucose intolerance and feeding behaviour disturbances in the aged rat. J. Endocrinol. 181: 291-296.
106. NYIRENDA, M.J., L.A.M. WELBERG & J.R. SECKL. 2001. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids - fetal effect or maternal influence? J. Endocrinol. 170: 653-660.
107. SLOBODA, D.M., J.P. NEWNHAM & J.R.G. CHALLIS. 2002. Repeated maternal glucocorticoid administration and the developing liver in fetal sheep. J. Endocrinol. 175: 535-543.
108. MOSS, T.J., D.M. SLOBODA, L.C. GURRIN, et al. 2001. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 281: R960-R970.
109. ROSELLA, G., J.D. ZAJAC, S.J. KACZMARCZYK, et al. 1993. Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol. Endocrinol. 7: 1456-1462.
110. VALERA, A., A. PUJOL, M. PELEGRIN & F. BOSCH. 1994. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91: 9151-9154.
111. DUONG, D.T., M.E. WALTNER-LAW, R. SEARS, et al. 2002. Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 277: 32234-32242.
112. CLEASBY, M.E., D.E.W. LIVINGSTONE, M.J. NYIRENDA, et al. 2003. Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? Eur. J. Endocrinol. 148: 129-138.
113. WHORWOOD, C.B., K.M. FIRTH, H. BUDGE & M.E. SYMONDS. 2001. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11 beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 142: 2854-2864.
114. DRAKE, A.J., B.R. WALKER & J.R. SECKL. 2005. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 288: R34-R38.
115. DRAKE, A.J. & B.R. WALKER. 2004. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J. Endocrinol. 180: 1-16.
116. CLEASBY, M.E., P.A.T. KELLY, B.R. WALKER & J.R. SECKL. 2003. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 144: 999-1007.
117. SCHUBRING, C., W. KIESS, P. ENGLARO, et al. 1997. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J. Clin. Endocrinol. Metab. 82: 1480-1483.
118. KOISTINEN, H.A., V.A. KOIVISTO, S. ANDERSSON, et al. 1997. Leptin concentration in cord blood correlates with intrauterine growth. J. Clin. Endocrinol. Metab. 82: 3328-3330.
119. JAQUET, D., J. LEGER, C. LEVY-MARCHAL, et al. 1998. Ontogeny of leptin inhuman fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. J. Clin. Endocrinol. Metab. 83: 1243-1246.
120. ONG, K.K., M.L. AHMED, A. SHERRIFF, et al. 1999. Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J. Clin. Endocrinol. Metab. 84: 1145-1148.
121. LEPERCQ, J., J.C. CHALLIER, M. GUERRE-MILLO, et al. 2001. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J. Clin. Endocrinol. Metab. 86: 2409-2413.
122. SMITH, J.T. & B.J. WADDELL. 2002. Leptin receptor expression in the rat placenta: changes in Ob-Ra, Ob-Rb, and Ob-Re with gestational age and suppression by glucocorticoids. Biol. Reprod. 67: 1204-1210.
123. STOCKER, C., J. O'DOWD, N.M. MORTON, et al. 2004. Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation. Int. J. Obes. Relat. Metab. Disord. 28: 129-136.
124. HU, E., P. LIANG & B.M. SPIEGELMAN. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271: 10697-10703.
125. WEYER, C., T. FUNAHASHI, S. TANAKA, et al. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86: 1930-1935.
126. LINDSAY, R., J. WALKER, P. HAVEL, et al. 2003. Adiponectin is present in cord blood but is unrelated to leptin and birth weight. Diabetes Care 26: 2244-2249.
127. GAROFANO, A., P. CZERNICHOW & B. BREANT. 1998. Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 41: 1114-1120.
128. GAROFANO, A., P. CZERNICHOW & B. BREANT. 1997. In utero undernutrition impairs rat beta-cell development. Diabetologia 40: 1231-1234.
129. BLONDEAU, B., J. LESAGE, P. CZERNICHOW, et al. 2001. Glucocorticoids impair fetal beta-cell development in rats. Am. J. Physiol. (Endocrinol. Metab.) 281: E592-E599.
130. SHEN, C.-N., J. SECKL, J. SLACK & D. TOSH. 2003. Glucocorticoids suppress beta cell development and induce hepatic metaplasia in embryonic pancreas. Biochem. J. 375: 41-50.
131. WELBERG, L.A.M. & J.R. SECKL. 2001. Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13: 113-128.
132. WEINSTOCK, M. 2001. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 65: 427-451.
133. KORTE, S.M. 2001. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 25: 117-142.
134. MEANEY, M.J., J. DIORIO, D. FRANCIS, et al. 1996. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Dev. Neurosci. 18: 49-72.
135. MEYER, J.S. 1983. Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp. Neurol. 82: 432-446.
136. HUANG, W.L., L.D. BEAZLEY, J.A. QUINLIVAN, et al. 1999. Effect of corticosteroids on brain growth in fetal sheep. Obstet. Gynecol. 94: 213-218.
137. HUANG, W.L., C.G. HARPER, S.F. EVANS, et al. 2001. Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int. J. Dev. Neurosci. 19: 487-493.
138. HUANG, W.L., C.G. HARPER, S.F. EVANS, et al. 2001. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int. J. Dev. Neurosci. 19: 415-425.
139. ANTONOW-SCHLORKE, I., M. SCHWAB, C. LI & P.W. NATHANIELSZ. 2003. Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J. Physiol. (Lond.) 547: 117-123.
140. MATTHEWS, S.G. 2000. Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res. 47: 291-300.
141. UNO, H., L. LOHMILLER, C. THIEME, et al. 1990. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. hippocampus. Dev. Brain Res. 53: 157-167.
142. SHELINE, Y.I., P.W. WANG, M.H. GADO, et al. 1996. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93: 3908-3913.
143. STEIN, M.B., C. KOVEROLA, C. HANNA, et al. 1997. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 27: 951-959.
144. BREMNER, J.D., P. RANDALL, T.M. SCOTT, et al. 1995. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder [comment]. Am. J. Psychiatry 152: 973-981.
145. FUXE, K., A.-C. WIKSTROM, S. OKRET, et al. 1985. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812.
146. DIAZ, R., R.W. BROWN & J.R. SECKL.1996. Corticosteroid receptors and 11β-hydroxysteroid dehydrogenases; crucial regulators of glucocorticoid action during fetal brain development. In Proceedings 40th Oholo Conference. E. GRAUER, D. BEN-NATHAN & A. LEVY, Eds.:Israel.
147. KITRAKI, E., C. KITTAS & F. STYLIANOPOULOU. 1997. Glucocorticoid receptor gene expression during rat embryogenesis: an in situ hybridization study. Differentiation 62: 21-31.
148. STEWART, P.M., B.A. MURRY & J.I. MASON. 1994. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 78: 1529-1532.
149. JACOBSON, L. & R. SAPOLSKY. 1991. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocr. Rev. 12: 118-134.
150. GOULD, E., C.S. WOOLLEY & B.S. MCEWEN. 1991. Adrenal steroids regulate postnatal development in the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J. Comp. Neurol. 313: 479-485.
151. GOULD, E., C.S. WOOLLEY, H.A. CAMERON, et al. 1991. Adrenal steroids regulate postnatal development in the rat dentate gyrus: II. Effects of glucocorticoids on cell birth. J. Comp. Neurol. 313: 486-493.
152. BOHN, M.C. 1980. Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience 5: 2003-2012.
153. WELBERG, L.A.M., J.R. SECKL & M.C. HOLMES. 2001. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 104: 71-79.
154. LANGLEY-EVANS, S.C., D.S. GARDNER & A.A. JACKSON. 1996. Maternal protein restriction influences the programming of the rat hypothalamic- pituitary-adrenal axis. J. Nutr. 126: 1578-1585.
155. HAWKINS, P., C. STEYN, H.H. MCGARRIGLE, et al. 2000. Cardiovascular and hypothalamic-pituitary-adrenal axis development in late gestation fetal sheep and young lambs following modest maternal nutrient restriction in early gestation. Reprod. Fertil. Dev. 12: 443-456.
156. WEINSTOCK, M., E. MATLINA, G.I. MAOR, et al. 1992. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res. 595: 195-200.
157. MCCORMICK, C.M., J.W. SMYTHE, S. SHARMA & M.J. MEANEY. 1995. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Dev. Brain Res. 84: 55-61.
158. UNO, H., S. EISELE, A. SAKAI, et al. 1994. Neurotoxicity of glucocorticoids in the primate brain. Horm. Behav. 28: 336-348.
159. DIAZ, R., K. FUXE & S.O. ÖGREN. 1997. Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 81: 129-140.
160. DIAZ, R., S.O. ÖGREN, M. BLUM & K. FUXE. 1995. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience 66: 467-473.
161. KOENIG, J.I., B. KIRKPATRICK & P. LEE. 2002. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27: 309-318.
162. CANLON, B., S. ERICHSEN, E. NEMLANDER, et al. 2003. Alterations in the intrauterine environment by glucocorticoids modifies the development programme of the auditory system. Eur. J. Neurosci. 17: 2035-2041.
163. DUNN, A. & C. BERRIDGE. 1990. Physiological and behavioral-responses to corticotropin-releasing factor administration - is crf a mediator of anxiety or stress responses. Brain Res. Rev. 15: 71-100.
164. WELBERG, L.A.M., J.R. SECKL & M.C. HOLMES. 2000. Inhibition of 11β-hydroxysteroid dehydrogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the offspring. Eur. J. Neurosci. 12: 1047-1054.
165. CRATTY, M.S., H.E. WARD, E.A. JOHNSON, et al. 1995. Prenatal stress increases corticotropin-releasing factor (Crf) content and release in rat amygdala minces. Brain Res. 675: 297-302.
166. HSU, D., F. CHEN, L. TAKAHASHI & N. KALIN. 1998. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res. 788: 305-310.
167. FELDMAN, S. & J. WEIDENFELD. 1998. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res. Bull. 45: 389-393.
168. TRONCHE, F., C. KELLENDONK, O. KRETZ, et al. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23: 99-103.
169. LEVINE, S. 1957. Infantile experience and resistance to physiological stress. Science 126: 405-406.
170. LEVINE, S. 1962. Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 135: 795-796.
171. MEANEY, M.J., D.H. AITKEN, C. VAN BERKEL, et al. 1988. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239: 766-768.
172. LIU, D., J. DIORIO, B. TANNENBAUM, et al. 1997. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277: 1659-1662.
173. MEANEY, M.J., D.H. AITKEN, V. VIAU, et al. 1989. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 50: 597-604.
174. MEANEY, M.J., D.H. AITKEN, S. SHARMA & V. VIAU. 1992. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticosteroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology 55: 204-213.
175. CATALANI, A., M. MARINELLI, S. SCACCIANOCE, et al. 1993. Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res. 624: 209-215.
176. SMYTHE, J.W., W.B. ROWE & M.J. MEANEY. 1994. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Dev. Brain Res. 80: 183-189.
177. MITCHELL, J.B., W. ROWE, P. BOKSA & M.J. MEANEY. 1990. Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J. Neurosci. 10: 1745-1752.
178. YAU, J.L.W., J. NOBLE & J.R. SECKL. 1997. Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following methylenedioxymethamphetamine: role of corticosterone and serotonin. Neuroscience 78: 111-121.
179. YAU, J.LW., J. NOBLE, J. WIDDOWSON & J.R. SECKL. 1997. Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Mol. Brain Res. 45: 182-186.
180. MEANEY, M.J., J. DIORIO, D. FRANCIS, et al. 2000. Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: the effects of thyroid hormones and serotonin. J. Neurosci. 20: 3926-3935.
181. ENCIO, I.J. & S.D. DETERA-WADLEIGH. 1991. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266: 7182-7188.
182. SLOTKIN, T.A., G.A. BARNES, E.C. MCCOOK & F.J. SEIDLER. 1996. Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Dev. Brain Res. 93: 155-161.
183. FUMAGALLI, F., S.R. JONES, M.G. CARON, et al. 1996. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res. 719: 225-228.
184. MCCORMICK, J., V. LYONS, M. JACOBSON, et al. 2000. 5′-heterogeneity of glucocorticoid receptor mRNA is tissue-specific; differential regulation of variant promoters by early life events. Mol. Endocrinol. 14: 506-517.
185. COLE, T.J., J.A. BLENDY, A.P. MONAGHAN, et al. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell-development and severely retards lung maturation. Genes Dev. 9: 1608-1621.
186. WEAVER, I., N. CERVONI, F. CHAMPAGNE, et al. 2004. Epigenetic programming by maternal behavior. Nat. Neurosci. 7: 847-854.
187. THOMASSIN, H., M. FLAVIN, M. ESPINAS & T. GRANGE. 2001. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 20: 1974-1983.
188. PEPIN, M.C., F. POTHIER & N. BARDEN. 1992. Impaired glucocorticoid receptor function in transgenic mice expressing antisense RNA. Nature 355: 725-728.
189. COLE, T.J., J.A. BLENDY, A.P. MONAGHAN, et al. 1995. Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 60: 93-96.
190. WEAVER, I.C.G., M. SZYF & M.J. MEANEY. 2002. From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocr. Res. 28: 699.
191. SECKL, J.R. & M.J. MEANEY. 2004. Glucocorticoid programming. Ann. N. Y. Acad. Sci.1032: 63-84.
192. DOYLE, L.W., G.W. FORD, N.M. DAVIS & C. CALLANAN. 2000. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci. 98: 137-142.
193. MACARTHUR, B.A., R.N. HOWIE, J.A. DEZOETE & J. ELKINS. 1982. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 70: 99-105.
194. TRAUTMAN, P.D., H.F.L. MEYER-BAHLBURG, J. POSTELNEK & M.I. NEW. 1995. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20: 439-449.
195. FRENCH, N.P., R. HAGAN, S. EVANS, et al. 1998. Repeated antenatal corticosteroids: behaviour outcomes in a regional population of very preterm infants (Abstract no. 1252). Pediatr. Res. 43: 214A.
196. YEH, T., Y. LIN, H. LIN, et al. 2004. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 350: 1304-1313.
197. CLARK, P.M., P.C. HINDMARSH, A.W. SHIELL, et al. 1996. Size at birth and adrenocortical function in childhood. Clin. Endocrinol. 45: 721-726.
198. PHILLIPS, D.I., C.H.D. FALL, C.B. WHORWOOD, et al. 1998. Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J. Clin. Endocrinol. Metab. 83: 757-760.
199. PHILLIPS, D.I.W., B.R. WALKER, R.M. REYNOLDS, et al. 2000. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35: 1301-1306.
200. LEVITT, N.S., E.V. LAMBERT, D. WOODS, et al. 2000. Impaired glucose tolerance and elevated blood pressure in low birth weight, non-obese young South African adults: early programming of the cortisol axis. J. Clin. Endocrinol. Metab. 85: 4611-4618.
201. REYNOLDS, R.M., B.R. WALKER, H.E. SYDDALL, et al. 2001. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 86: 245-250.
202. TURNER, J.D. & C.P. MULLER. 2005. Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. J. Mol. Endocrinol. 35: 283-292.
203. YEHUDA, R. 2002. Current concepts - post-traumatic stress disorder. N. Engl. J. Med. 346: 108-114.
204. YEHUDA, R., J.A. GOLIER, R.K. YANG & L. TISCHLER. 2004. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 55: 1110-1116.
205. YEHUDA, R., S.M. ENGEL, S.R. BRAND, et al. 2005. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the world trade center attacks during pregnancy. J. Clin. Endocrinol. Metab. 90: 4115-4118.
206. BERKOWITZ, G.S., M.S. WOLFF, T.M. JANEVIC, et al. 2003. The World Trade Center disaster and intrauterine growth restriction. JAMA 290: 595-596.
207. ENGEL, S.M., G.S. BERKOWITZ, M.S. WOLFF & R. YEHUDA. 2005. Psychological trauma associated with the World Trade Center attacks and its effect on pregnancy outcome. Paediatr. Perinat. Epidemiol. 19: 334-341.